Everolimus Plus Exemestane in Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting
Oncologist 2017 Apr 21;[EPub Ahead of Print], D Generali, F Montemurro, R Bordonaro, A Mafodda, S Romito, A Michelotti, P Piovano, MT Ionta, C Bighin, D Sartori, A Frassoldati, ME Cazzaniga, F Riccardi, F Testore, P Vici, CA Barone, A Schirone, F Piacentini, F Nolè, A Molino, L Latini, EL Simoncini, F Roila, F Cognetti, F Nuzzo, J Foglietta, AM Minisini, F Goffredo, G Portera, G Ascione, G MarianiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.